ストックスクリーナーアプリを入手
4.93
4.09%
-0.21
前日終値:
$5.14
開ける：
$5.14
24時間の取引高:
3.50M
Relative Volume:
0.86
時価総額：
$1.15B
収益：
$251.85M
当期純損益:
$-72.58M
株価収益率:
-15.73
EPS:
-0.3134
ネットキャッシュフロー:
$-63.80M
1週間 パフォーマンス:
-3.90%
1か月 パフォーマンス:
-5.56%
6か月 パフォーマンス:
-25.86%
1年 パフォーマンス:
-32.47%
1日の値動き範囲:
$4.91
$5.14
1週間の範囲:
$4.91
$5.365
52週間の値動き範囲:
$4.32
$9.33
Ardelyx Inc Stock (ARDX) Company Profile
ARDX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
4.93 | 1.15B | 251.85M | -72.58M | -63.80M | -0.3134 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-07 | 再開されました | Ladenburg Thalmann | Buy |
| 2025-03-04 | 開始されました | BTIG Research | Buy |
| 2024-11-11 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | 開始されました | Leerink Partners | Outperform |
| 2023-12-18 | 開始されました | Raymond James | Strong Buy |
| 2023-09-07 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-25 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | アップグレード | Wedbush | Neutral → Outperform |
| 2022-11-17 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | ダウングレード | Jefferies | Buy → Hold |
| 2021-07-20 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | ダウングレード | Wedbush | Outperform → Neutral |
| 2021-03-23 | 開始されました | Wedbush | Outperform |
| 2021-01-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-10-20 | 再開されました | Citigroup | Buy |
| 2020-02-18 | 再開されました | Jefferies | Buy |
| 2020-02-12 | 開始されました | Citigroup | Buy |
| 2020-02-10 | 開始されました | Cowen | Outperform |
| 2019-04-08 | 開始されました | Piper Jaffray | Overweight |
| 2018-08-24 | 開始されました | Jefferies | Buy |
| 2018-03-19 | 再開されました | Leerink Partners | Outperform |
| 2017-11-29 | 繰り返されました | Citigroup | Buy |
| 2017-11-22 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2017-10-17 | 再開されました | Leerink Partners | Outperform |
| 2016-03-31 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-03-09 | 開始されました | Cantor Fitzgerald | Buy |
| 2016-03-03 | 開始されました | Citigroup | Buy |
すべてを表示
Ardelyx Inc (ARDX) 最新ニュース
Institutional owners may take dramatic actions as Ardelyx, Inc.'s (NASDAQ:ARDX) recent 6.4% drop adds to one-year losses - Simply Wall St
How to Take Advantage of moves in (ARDX) - Stock Traders Daily
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - Marketscreener.com
ARDELYX INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
Trading (ARDX) With Integrated Risk Controls - Stock Traders Daily
Ardelyx honors inaugural Derek Forfang award winners By Investing.com - Investing.com Australia
Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth - Investing.com
Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth By Investing.com - Investing.com UK
Ardelyx honors inaugural Derek Forfang award winners - Investing.com India
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award - The Manila Times
Five Champions of Kidney Disease Advocacy Receive Groundbreaking Ardelyx Recognition - StockTitan
Insider Buying: David Mott Acquires Shares of Ardelyx Inc (ARDX) - GuruFocus.com
Piper Sandler maintains $8 target on Ardelyx shares amid uncertainty By Investing.com - Investing.com South Africa
Piper Sandler maintains $8 target on Ardelyx shares amid uncertainty - Investing.com India
8,020 Shares in Ardelyx, Inc. (NASDAQ:ARDX) Bought by SBI Securities Co. Ltd. - Defense World
Ardelyx at Leerink Global Healthcare Conference: Navigating Challenges and Opportunities By Investing.com - Investing.com South Africa
Ardelyx at Leerink Global Healthcare Conference: Navigating Challenges and Opportunities - Investing.com India
High Growth Tech Stocks In The US With Promising Potential - Simply Wall St
Ardelyx (NASDAQ:ARDX) Earns “Buy” Rating from LADENBURG THALM/SH SH - Defense World
Ardelyx CEO Michael Raab sells $223,198 in stock - Investing.com
Scotiabank sets $15 target for Ardelyx stock, sees growth potential - Investing.com
Scotiabank sets $15 target for Ardelyx stock, sees growth potential By Investing.com - Investing.com South Africa
Ardelyx, Inc. to Host Earnings Call - ACCESS Newswire
Cantor Fitzgerald Predicts Ardelyx FY2025 Earnings - Defense World
Ardelyx (NASDAQ:ARDX) Raised to Strong-Buy at Cantor Fitzgerald - Defense World
Rhumbline Advisers Purchases 6,070 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Ardelyx (NASDAQ:ARDX) Coverage Initiated by Analysts at BTIG Research - Defense World
BTIG sets Ardelyx stock Buy rating, $14 price target - Investing.com India
BTIG sets Ardelyx stock Buy rating, $14 price target By Investing.com - Investing.com South Africa
BTIG Initiates Ardelyx at Buy With $14 Price Target -March 04, 2025 at 07:10 am EST - Marketscreener.com
BTIG initiates Ardelyx with a Buy, sees attractive entry point after pullback - TipRanks
Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Ardelyx, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire
Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire
Reviewing Q32 Bio (NASDAQ:QTTB) & Ardelyx (NASDAQ:ARDX) - Defense World
Shareholders That Lost Money on Ardelyx, Inc. (ARDX) Should Contact Levi & Korsinsky About Pending Class ActionARDX - ACCESS Newswire
Undercovered Dozen: Ardelyx, Aviva, Nutrien, Heartland Express + - Seeking Alpha
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - ACCESS Newswire
Los Angeles Capital Management LLC Has $2.38 Million Stock Position in Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
Ardelyx (NASDAQ:ARDX) Stock Price Up 5.3% on Insider Buying Activity - MarketBeat
ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Shareholders of Ardelyx, Inc. Should Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire
ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Levi & Korsinsky Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire
Shareholders that lost money on Ardelyx, Inc. (ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Insider Buying: Ardelyx, Inc. (NASDAQ:ARDX) Director Buys 77,729 Shares of Stock - MarketBeat
Wedbush Estimates Ardelyx's FY2029 Earnings (NASDAQ:ARDX) - MarketBeat
FINAL ARDX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Ardelyx, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
HC Wainwright Estimates Ardelyx FY2029 Earnings - MarketBeat
Ardelyx (NasdaqGM:ARDX) Gets US$5M Milestone From China NDA Approval For Tenapanor In Dialysis Patients - Simply Wall St
Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Ardelyx Inc (ARDX) 財務データ
収益
当期純利益
現金流量
EPS
Ardelyx Inc (ARDX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| RAAB MICHAEL | President & CEO |
Mar 07 '25 |
Option Exercise |
0.99 |
20,834 |
20,626 |
1,676,806 |
| RAAB MICHAEL | President & CEO |
Mar 07 '25 |
Sale |
5.36 |
41,668 |
223,199 |
1,635,138 |
| MOTT DAVID M | Director |
Feb 24 '25 |
Buy |
5.00 |
77,729 |
388,738 |
2,015,494 |
| Williams Laura A | Chief Medical Officer |
Feb 20 '25 |
Sale |
5.62 |
4,941 |
27,783 |
303,804 |
| Renz Justin A | Chief Financial Officer |
Feb 20 '25 |
Sale |
5.62 |
5,171 |
29,077 |
285,968 |
| RAAB MICHAEL | President & CEO |
Feb 20 '25 |
Sale |
5.62 |
22,964 |
129,124 |
1,085,755 |
| GRAMMER ELIZABETH A | See Remarks |
Feb 20 '25 |
Sale |
5.62 |
4,291 |
24,128 |
181,043 |
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):